Ameritas Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.31M | Sell |
12,441
-9,874
| -44% | -$1.83M | 0.12% | 170 |
|
2025
Q1 | $4.27M | Sell |
22,315
-1,621
| -7% | -$310K | 0.17% | 130 |
|
2024
Q4 | $4.25M | Buy |
23,936
+3,657
| +18% | +$650K | 0.15% | 135 |
|
2024
Q3 | $4M | Sell |
20,279
-3,979
| -16% | -$786K | 0.17% | 129 |
|
2024
Q2 | $4.16M | Sell |
24,258
-2,013
| -8% | -$345K | 0.16% | 132 |
|
2024
Q1 | $4.49M | Buy |
26,271
+7,280
| +38% | +$1.25M | 0.19% | 105 |
|
2023
Q4 | $3.15M | Sell |
18,991
-8,626
| -31% | -$1.43M | 0.17% | 118 |
|
2023
Q3 | $4.12M | Buy |
27,617
+16,362
| +145% | +$2.44M | 0.21% | 99 |
|
2023
Q2 | $1.53M | Sell |
11,255
-13,614
| -55% | -$1.84M | 0.2% | 120 |
|
2023
Q1 | $4.03M | Sell |
24,869
-7,557
| -23% | -$1.22M | 0.2% | 98 |
|
2022
Q4 | $5.24M | Buy |
32,426
+3,550
| +12% | +$574K | 0.24% | 97 |
|
2022
Q3 | $3.88M | Buy |
28,876
+86
| +0.3% | +$11.5K | 0.23% | 93 |
|
2022
Q2 | $4.41M | Buy |
28,790
+2,490
| +9% | +$381K | 0.26% | 84 |
|
2022
Q1 | $4.26M | Buy |
26,300
+1,215
| +5% | +$197K | 0.16% | 99 |
|
2021
Q4 | $3.4M | Buy |
+25,085
| New | +$3.4M | 0.12% | 142 |
|